The effect of green tea in the treatment of Alzheimer's disease
Phase 3
- Conditions
- Alzheimer.Other Alzheimer disease
- Registration Number
- IRCT201402233684N5
- Lead Sponsor
- Babol University of Medical Sciences Research ?Deputy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Alzheimer's disease
Inclusion Exclusion: Taking vitamin and antioxidant supplements; drugs interfering; inflammatory diseases; acute and chronic infectious disease; thalassemia; diabetes; hepatitis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: TBARS Method (spectrophotometry).;Total antioxidant capacity. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: FRAP Method.;8-OH-2-deoxy-Guanosine. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: ELISA.;Carbonyl. Timepoint: Before intervention, 2 months after the end of intervention. Method of measurement: Levin Method.
- Secondary Outcome Measures
Name Time Method